[Treatment of hemophiliacs with inhibitors].
D000328:Adult; D000906:Antibodies / Q000032:analysis; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002648:Child; D005164:Factor IX / Q000627:therapeutic use*; D015949:Factor IXa; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D002836:Hemophilia B / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008875:Middle Aged
D000906:Antibodies; D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa